In a historic event held at the Indian Institute of Technology (IIT) Bombay, President Droupadi Murmu marked a momentous occasion with the launch of India's first indigenous CAR T-cell therapy for cancer treatment. This groundbreaking therapy, named NexCAR19, developed jointly by IIT Bombay and Tata Memorial Centre, signifies a significant advancement in India's medical research and underscores the success of the 'Make in India' initiative.

A Game-Changing Breakthrough

CAR T-cell therapy is recognized as a revolutionary approach in medical science, and its development within India is an evidence of the prowess of Indian scientists and physicians. President Murmu emphasized the importance of this achievement, stating that it represents a new ray of hope in the global battle against cancer. She highlighted the therapy's accessibility and affordability, which will undoubtedly benefit countless individuals worldwide.

Affordable Treatment, Global Impact

Sudeep Gupta, Director of Tata Memorial Centre, shed light on the economic aspect of this breakthrough. He revealed that NexCAR19 is priced at approximately one-tenth of its cost outside India, making this life-saving treatment accessible to a broader population. This significant reduction in cost is a game-changer for cancer patients, offering hope and relief to those previously unable to afford such advanced therapies.

From Costly to Accessible: The Impact of NexCAR19

Prof. Subhasis Chaudhuri, Director of IIT Bombay, elaborated on the exorbitant costs associated with similar treatments abroad, citing a staggering figure of ₹4 crore. The development and deployment of NexCAR19 at a significantly lower cost in India mark a monumental achievement in cancer care. This achievement not only positions India as a leader in cell and gene therapy but also underscores the nation's commitment to making critical medical innovations accessible to all.

A Historic Milestone in Cancer Care

Mr. Gupta emphasized the historic significance of NexCAR19, describing it as a turning point in the field of cancer care and genetic engineering. He expressed confidence that this therapy will save countless lives and alleviate the suffering of many families affected by cancer. The practical application of NexCAR19 is poised to transform the landscape of cancer treatment, not only in India but globally.

Looking Ahead: Hope and Healing

This pioneering therapy not only represents a breakthrough in medical science but also provides hope for those battling cancer. With affordability and accessibility at its core, NexCAR19 promises to redefine cancer treatment and pave the way for a brighter, healthier future.